ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Natural Bladder Control, Go Less and Live More

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Top Vitamin and Mineral Deficiencies — Are You at Risk?

How Pomegranate May Protect Against Cancer

Omega Fix for Obesity: How the Right Fats Fight Fat

Trimming the spare tire: Canola oil may cut belly fat

The Onion: Cancer Fighter and Food Preserver

Fighting Heartburn and Gerd Naturally – And Safely!

Probiotics improve cognition in Alzheimer's patients

Safely Reduce a Common Cause of Stomach Distress

 
Print Page
Email Article

Over-the-Counter Pain Relievers Effective in Protecting Against Breast Cancer

  [ 71 votes ]   [ Discuss This Article ]
www.ProHealth.com • April 8, 2003


NSAIDs may block development of breast tumors

Philadelphia, PA – Regular use of ibuprofen and aspirin inhibits the formation and growth of breast cancer, according to data published in the Proceedings for the 94th Annual Meeting of the American Association for Cancer Research (AACR). The data, taken from the National Cancer Institute's (NCI) Women's Health Initiative (WHI) Observational Study, concluded that weekly doses of non-steroidal anti-inflammatory drugs (NSAIDs) had a significant effect in reducing the risk of breast cancer.

"These results suggest that even women at high risk for breast cancer may be protected by taking NSAIDs," explains Randall Harris, M.D., Ph.D., lead investigator of the study, professor of the division of epidemiology and biometrics at the Ohio State University. "However, before usage guidelines for NSAIDs can be implemented, additional studies are needed."

This study found that women taking two or more NSAIDs per week (considered regularly) for five to nine years reduced their risk of breast cancer by 21 percent. Extending the use to ten or more years resulted in an even greater reduction of 28 percent. The probability of developing breast cancer was estimated and adjusted for age and other breast cancer risk factors (e.g. body mass, estrogen use, family history, and exercise). Researchers observed that ibuprofen was more effective than aspirin in preventing breast cancer (49 percent vs. 21 percent). Regular use of low-dose aspirin (<100 mg) had no effect.

The goal of chemoprevention for breast and other cancers is to identify or develop specifically-targeted agents with minimal toxicity that will delay, block, or reverse cancer development. Early epidemiologic investigations have shown that NSAIDs potentially limit breast cancer development, and preclinical studies have supported this finding by showing that they limit the growth of tumors in the breast. The primary mechanism of action of these drugs is the inhibition of COX-2, which is over-expressed in most human breast cancers. Recent studies indicate that COX-2 – an inducible enzyme generating prostaglandins (PG) – may be implicated in several biological events throughout the process of tumor development and therefore is a potential target for preventing and possibly treating a number of cancers.

The WHI is an observational study that enrolled 80,741 post-menopausal women between 50 and 79 years of age with no reported history of any cancer, other than non-melanoma skin cancer. Each woman completed a personal interview, which collected information on their individual risk of developing breast cancer and their use of NSAIDs, such as ibuprofen and aspirin. Of those enrolled, 1,392 were later diagnosed with breast cancer.

Based on WHI protocol, each participant provided an annual medical history update. Breast cancer diagnoses were confirmed by WHI physicians using pathology reports. Average follow-up was 43 months. Even after adjusting for demographics and several potential risk factors, the observed effects of long-term use of NSAIDs in reducing breast cancer risk remained stable.

The annual incidence of breast cancer in the WHI study (481 cases per 100,000) is similar to the incidence of breast cancer estimated for women over the age of 50, according to the 1998 National Cancer Institute SEER data (478 per 100,000). More than 212,600 new cases of breast cancer will be diagnosed and nearly 40,000 women will die in 2003, according to the American Cancer Society. Breast cancer is the second leading cause of cancer-related death in women.


Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 20,000 laboratory and clinical scientists engaged in cancer research in the United States and more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention). AACR's annual meeting attracts more than 12,000 participants who share new and significant discoveries in the cancer field, and the AACR's specialty meetings throughout the year focus on all the important areas of basic, translational and clinical cancer research.



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Energy NADH™ 12.5mg Ultra EPA  - Fish Oil


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Eating Fat is Good... Maybe... Could Be... Sometimes Eating Fat is Good... Maybe... Could Be... Sometimes
Herbal Rescue for High Blood Sugar Herbal Rescue for High Blood Sugar
Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea
Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial
Herbal Inflammation Management for Whole Body Health Herbal Inflammation Management for Whole Body Health

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map